兄弟科技(002562.SZ):兄弟維生素擬購買實控人擁有的房產 作為人才宿舍
格隆匯12月22日丨兄弟科技(002562.SZ)公佈,為給公司全資子公司江蘇兄弟維生素有限公司(“兄弟維生素”)管理層、業務骨幹、大學生等人才提供良好的生活及居住環境,兄弟維生素擬通過現金方式購買公司控股股東、實際控制人錢志達擁有的房產(包括住宅及附屬物,“該房產”)作為兄弟維生素人才宿舍,住宅建築面積合計3443.09平方米,交易總價為3548.3448萬元,此次交易構成關聯交易。
此次交易的房產坐落於江蘇省鹽城市大豐區常新路57號上海花園,共計26套住宅(帶裝修)及附屬物,住宅均已取得大豐市房產管理局頒發的《房屋所有權證》和大豐市國土資源局頒發的《國有土地使用證》,住宅建築面積合計3443.09平方米,登記用途為住宅,符合其再上市政策規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.